Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lamy

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
The Review of Scientific Instruments|March 5, 2008
The ECRIS charge state breeding project at TRIUMFF Ames, R Baartman, P Bricault, et al.
Chemistry and Physics of Lipids|November 24, 2020
The interaction of a thiosemicarbazone derived from R - (+) - limonene with lipid membranesC A Marquezin, C M A de Oliveira, F Vandresen, et al.
Leukemia & Lymphoma|July 21, 1998
Prophylactic use of itraconazole for the prevention of invasive pulmonary aspergillosis in high risk neutropenic patientsT Lamy, M Bernard, A Courtois, et al.
The Review of Scientific Instruments|March 3, 2010
SEISM: a 60 GHz cusp electron cyclotron resonance ion sourceL Latrasse, M Marie-Jeanne, T Lamy, et al.
Blood|April 15, 1997
CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistanceB Drénou, T Lamy, L Amiot, et al.
Leukemia|November 1, 1994
P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML)T Lamy, J E Goasguen, E Mordelet, et al.
The Review of Scientific Instruments|March 5, 2008
Study of pulsed electron cyclotron resonance ion source plasma near breakdown: the preglowT Thuillier, T Lamy, L Latrasse, et al.
Leukemia Research|June 5, 2007
Clinical spectrum of gammadelta+ T cell LGL leukemia: analysis of 20 casesA S Bourgault-Rouxel, T P Loughran, R Zambello, et al.
Cancer|October 20, 1999
Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS GroupN Ifrah, F Witz, J P Jouet, et al.
Leukemia & Lymphoma|July 1, 1996
Idarubicin and high dose cytarabine: a new salvage treatment for refractory or relapsing non-Hodgkin's lymphomaP Dufour, R Mors, P Berthaud, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
The Review of Scientific Instruments|March 5, 2008
The ECRIS charge state breeding project at TRIUMFF Ames, R Baartman, P Bricault, et al.
Chemistry and Physics of Lipids|November 24, 2020
The interaction of a thiosemicarbazone derived from R - (+) - limonene with lipid membranesC A Marquezin, C M A de Oliveira, F Vandresen, et al.
Leukemia & Lymphoma|July 21, 1998
Prophylactic use of itraconazole for the prevention of invasive pulmonary aspergillosis in high risk neutropenic patientsT Lamy, M Bernard, A Courtois, et al.
The Review of Scientific Instruments|March 3, 2010
SEISM: a 60 GHz cusp electron cyclotron resonance ion sourceL Latrasse, M Marie-Jeanne, T Lamy, et al.
Blood|April 15, 1997
CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistanceB Drénou, T Lamy, L Amiot, et al.
Leukemia|November 1, 1994
P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML)T Lamy, J E Goasguen, E Mordelet, et al.
The Review of Scientific Instruments|March 5, 2008
Study of pulsed electron cyclotron resonance ion source plasma near breakdown: the preglowT Thuillier, T Lamy, L Latrasse, et al.
Leukemia Research|June 5, 2007
Clinical spectrum of gammadelta+ T cell LGL leukemia: analysis of 20 casesA S Bourgault-Rouxel, T P Loughran, R Zambello, et al.
Cancer|October 20, 1999
Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS GroupN Ifrah, F Witz, J P Jouet, et al.
Leukemia & Lymphoma|July 1, 1996
Idarubicin and high dose cytarabine: a new salvage treatment for refractory or relapsing non-Hodgkin's lymphomaP Dufour, R Mors, P Berthaud, et al.
Pageof 14